Health screening tests help identify conditions that may require attention during your treatment and throughout survivorship. Ackerman Cancer Center recommends that patients follow the screening guidelines laid out by the American Cancer Society. You can view the guidelines here, broken down by age for your convenience.
At Ackerman Cancer Center, we provide the following screening and diagnostic tests on-site for our patients. With all your care managed in one place, you no longer have to worry about traveling to multiple facilities for your tests and you are always able to receive your results the same day.
Bone Density: This is a low-level X-ray scan that measures bone mineral density. It allows your physician to evaluate and monitor your bone health, determine the likelihood of osteoporosis, and detect whether cancer has metastasized.
Low-Dose Computed Tomography (CT): A low-dose CT takes several 3-D X-ray images of the lungs, providing much more detail than traditional X-rays. These CT scans are often able to detect early-stage lung cancers that may be too small to be detected by traditional X-rays.
Digital Mammography with Computer-Aided Detection (CAD): Digital imaging is used to search for abnormal areas of density, mass, or calcification that may indicate the presence of cancer.
Prostate Specific Antigen (PSA) Test: The PSA test measures the level of prostate-specific antigen in a man’s blood. A sample of blood is taken and analyzed to screen for prostate cancer.
Axumin Scan: These PET imaging injections are used for men with suspected recurrence of prostate cancer based on elevated PSA following initial treatment. The scan identifies the location and extent of the recurrence earlier than CT or MRI scans alone.
Biopsy: A sample of tissue taken from the body to examine more closely, after an initial test suggests that there is an abnormality.
Diagnostic Computed Tomography (CT): Similar to a traditional X-ray but with a higher level of detail, CTs take accurate 3D images of the brain and body.
Genetic Testing: Assesses for specific, inherited changes (mutations) in your genes. Genetic testing for cancer is a predictive test to see if a person has a mutation known to increase cancer risk.
Magnetic Resonance Imaging (MRI): An MRI uses a magnetic field and pulses of radio wave energy to develop images of organs and structures within the body. It gives different information about body structures than what can be found in an X-ray, ultrasound, or CT scan.
Positron Emission Tomography/Computed Tomography (PET/CT): This merges a CT with a PET scan to record multiple views of the body. In a PET scan, the patient is injected with a small amount of radioactive sugar. Cancer cells will consume much of the sugar, allowing the scanned image to produce precise images of a tumor.
Prostate Cancer Gene 3 Test (PCA3): A prostate cancer-specific urine test that provides additional information to more accurately predict prostate biopsy outcome, and determine whether or not a biopsy is required.
Ultrasound-guided biopsies use sound waves to help locate a lump or abnormality and remove a tissue sample for examination under a microscope for breast cancer patients. It is less invasive than surgical biopsy and leaves little to no scarring.
Thyroid & neck ultrasounds produce images of the thyroid gland and adjacent structures in the neck. They help determine whether a thyroid nodule is benign or requires further testing.